Nme2Cas9‐mediated therapeutic editing in inhibiting angiogenesis after wet age‐related macular degeneration onset

Abstract Background Age‐related macular degeneration (AMD), particularly wet AMD characterised by choroidal neovascularization (CNV), is a leading cause of vision loss in the elderly. The hypoxia‐inducible factor‐1α (HIF‐1α)/vascular endothelial growth factor (VEGF)/VEGF receptor 2 (VEGFR2) pathway...

Full description

Bibliographic Details
Published in:	Clinical and Translational Medicine
Main Authors:	Sihui Hu, Yuxi Chen, Dongchun Xie, Kan Xu, Yunzhao Fu, Wei Chi, Haiying Liu, Junjiu Huang
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Subjects:	choroidal neovascularization gene editing gene therapy Nme2Cas9 wet AMD
Online Access:	https://doi.org/10.1002/ctm2.1383

Similar Items

CRISPR‐based gene therapy for wet age‐related macular degeneration in mouse model
by: Dongchun Xie, et al.
Published: (2024-02-01)

Subretinal Drug Delivery in Wet Age Related Macular Degeneration with Sub-macular Hemorrhage
by: Atul Kumar, et al.
Published: (2014-10-01)

Current and Novel Therapeutic Approaches for Treatment of Neovascular Age-Related Macular Degeneration
by: Reem H. ElSheikh, et al.
Published: (2022-11-01)

OCT Angiography-based Evaluation of the Choriocapillaris in Neovascular Age-related Macular Degeneration
by: Varsha Pramil, et al.
Published: (2021-10-01)

Gene Therapy for Wet Age-Related Macular Degeneration
by: Normila Barthelemy, et al.
Published: (2025-10-01)

Genetic Insights into Age-Related Macular Degeneration
by: Bhumika, et al.
Published: (2024-07-01)

Dry and neovascular “wet” age-related macular degeneration: Upcoming therapies
by: Audrey Yan, et al.
Published: (2025-01-01)

Vitrectomy for full-thickness macular hole developed during aflibercept treatment for wet age-related macular degeneration
by: Agnieszka Nowosielska
Published: (2024-12-01)

Patterns of Gene Expression, Splicing, and Allele-Specific Expression Vary among Macular Tissues and Clinical Stages of Age-Related Macular Degeneration
by: Treefa Shwani, et al.
Published: (2023-11-01)

Age-Related Macular Degeneration: Classification and Pathogenesis
by: İmren Akkoyun
Published: (2014-12-01)

Two Year Study of Aflibercept and Ranibizumab Intravitreal Therapy in Patients with Wet AMD
by: Dorota Luksa, et al.
Published: (2021-11-01)

Intraocular Tuberculosis: A Challenging Case Mimicking Wet Age-Related Macular Degeneration
by: Emanuela Interlandi, et al.
Published: (2021-06-01)

Rac1 overexpression promotes Treg-derived cytokines to mediate choroidal neovascularization in wet age-related macular degeneration
by: Juanjuan Li, et al.
Published: (2025-03-01)

Analysis of Clinical Study Results Obtained in Patients with Neovascular Age-Related Macular Degeneration in 2005–2020. Review
by: N. A. Gavrilova, et al.
Published: (2022-04-01)

Recent Developments in Gene Therapy for Neovascular Age-Related Macular Degeneration: A Review
by: Lucia Finocchio, et al.
Published: (2023-12-01)

Treatment Strategies for Anti-VEGF Resistance in Neovascular Age-Related Macular Degeneration by Targeting Arteriolar Choroidal Neovascularization
by: Yingbin Fu, et al.
Published: (2024-02-01)

Pachychoroid neovasculopathy can mimic wet type age-related macular degeneration
by: Mohsen Farvardin, et al.
Published: (2022-10-01)

Clinical Response To Switch From Ranibizumab To Aflibercept In Wet Age-Related Macular Degeneration
by: Bhagya Weerasinghe, et al.
Published: (2021-01-01)

Three-year follow-up of ranibizumab treatment of wet age-related macular degeneration: influence of baseline visual acuity and injection frequency on visual outcomes
by: Razi F, et al.
Published: (2016-02-01)

Exploring the role of granzyme B in subretinal fibrosis of age-related macular degeneration
by: Karanvir Gill, et al.
Published: (2024-07-01)

Systemic Dendrimer-Peptide Therapies for Wet Age-Related Macular Degeneration
by: Tony Wu, et al.
Published: (2023-10-01)

Age-Related Macular Degeneration: Therapeutic Strategies and Future Approaches
by: Răzvan Vasile ROPCIUC
Published: (2024-05-01)

Biomarkers for the Progression of Intermediate Age-Related Macular Degeneration
by: Eleonora M. Lad, et al.
Published: (2023-09-01)

Polymorphic nanobody crystals as long‐acting intravitreal therapy for wet age‐related macular degeneration
by: Shuqian Zhu, et al.
Published: (2023-11-01)

Vps28 Is Involved in the Intracellular Trafficking of Awd, the Drosophila Homolog of NME1/2
by: Elisa Mezzofanti, et al.
Published: (2019-08-01)

The relation between SNPs in the NME1 gene and response to sofosbuvir in Egyptian patients with chronic HCV
by: Mohamed AbdElrahman, et al.
Published: (2023-01-01)

Real-World 5-Year Outcomes of Age-Related Macular Degeneration with Bevacizumab as First-Line Anti-VEGF
by: H. Mhmud, et al.
Published: (2025-06-01)

RGD-Functionalized Ginsenoside Rg3 Liposomes for Alleviating Oxidative Stress and Choroidal Neovascularization in Age-Related Macular Degeneration
by: Zhou J, et al.
Published: (2025-06-01)

Mitochondrial NME6: A Paradigm Change within the NME/NDP Kinase Protein Family?
by: Bastien Proust, et al.
Published: (2024-07-01)

A Review of Age-related Macular Degeneration and Current Concepts in Management
by: Sahebaan Sethi
Published: (2024-12-01)

Engineered domain-inlaid Nme2Cas9 adenine base editors with increased on-target DNA editing and targeting scope
by: Ding Zhao, et al.
Published: (2023-11-01)

A comprehensive review on early detection of drusen patterns in age-related macular degeneration using deep learning models
by: Kiruthika M, et al.
Published: (2025-02-01)

Pemafibrate prevents choroidal neovascularization in a mouse model of neovascular age-related macular degeneration
by: Deokho Lee, et al.
Published: (2023-01-01)

Morphological and functional retinal changes in neovascular age-related macular degeneration treated with intravitreal bevacizumab
by: Deepali R Damkondwar, et al.
Published: (2022-01-01)

Role of IL-4 in bone marrow driven dysregulated angiogenesis and age-related macular degeneration
by: Takashi Baba, et al.
Published: (2020-05-01)

Etiological Roles of p75<sup>NTR</sup> in a Mouse Model of Wet Age-Related Macular Degeneration
by: Paula Virginia Subirada, et al.
Published: (2023-01-01)

The role of peripheral blood microRNAs in the pathogenesis and treatment response of age-related macular degeneration
by: Meng Kong, et al.
Published: (2025-12-01)

New Frontiers in Retina: highlights of the 2020 angiogenesis, exudation and degeneration symposium
by: Carmen A. Puliafito, et al.
Published: (2020-05-01)

Initial experience with brolucizumab for neovascular age-related macular degeneration (nAMD) in India – Multicentric, real-world study
by: Deependra Vikram Singh, et al.
Published: (2024-12-01)

Dysregulated serum lipid profiles in neovascular age-related macular degeneration revealed by UPLC‒MS/MS lipidomics
by: Yuan Qu, et al.
Published: (2025-09-01)